1,2,3,6-Tetrahydropyridine
1,2,3,6-Tetrahydropyridine structure
|
Common Name | 1,2,3,6-Tetrahydropyridine | ||
|---|---|---|---|---|
| CAS Number | 694-05-3 | Molecular Weight | 83.132 | |
| Density | 0.9±0.1 g/cm3 | Boiling Point | 110.9±9.0 °C at 760 mmHg | |
| Molecular Formula | C5H9N | Melting Point | −48 °C(lit.) | |
| MSDS | USA | Flash Point | 16.1±0.0 °C | |
| Symbol |
GHS02, GHS07 |
Signal Word | Danger | |
| Name | 3-piperideine |
|---|---|
| Synonym | More Synonyms |
| Density | 0.9±0.1 g/cm3 |
|---|---|
| Boiling Point | 110.9±9.0 °C at 760 mmHg |
| Melting Point | −48 °C(lit.) |
| Molecular Formula | C5H9N |
| Molecular Weight | 83.132 |
| Flash Point | 16.1±0.0 °C |
| Exact Mass | 83.073502 |
| PSA | 12.03000 |
| LogP | 1.05 |
| Vapour Pressure | 23.3±0.2 mmHg at 25°C |
| Index of Refraction | 1.455 |
| Symbol |
GHS02, GHS07 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H315-H319-H335 |
| Precautionary Statements | P210-P261-P305 + P351 + P338 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
| Hazard Codes | F: Flammable;Xi: Irritant; |
| Risk Phrases | R11 |
| Safety Phrases | S16-S26-S36/37/39 |
| RIDADR | UN 2410 3/PG 2 |
| WGK Germany | 3 |
| Packaging Group | II |
| Hazard Class | 3.1 |
| HS Code | 2933399090 |
| Precursor 9 | |
|---|---|
| DownStream 10 | |
CAS#:2589-31-3
CAS#:2876-13-3
CAS#:40240-12-8
CAS#:52003-32-4
CAS#:462-08-8
CAS#:110-86-1
CAS#:100-39-0
CAS#:85839-08-3
CAS#:694-55-3
CAS#:37656-48-7
CAS#:104774-88-1
CAS#:180161-17-5
CAS#:18513-75-2
CAS#:18065-78-6
CAS#:26905-02-2
CAS#:100129-35-9
CAS#:99329-53-0
CAS#:85838-94-4
CAS#:771-99-3| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
The highly-selective 5-HT(1A) agonist F15599 reduces L-DOPA-induced dyskinesia without compromising anti-parkinsonian benefits in the MPTP-lesioned macaque.
Neuropharmacology 97 , 306-11, (2015) L-3,4-dihydroxyphenylalanine (L-DOPA) is the most effective anti-parkinsonian agent available, but upon chronic administration, patients with Parkinson's disease (PD) experience abnormal involuntary m... |
|
|
Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice.
Neuropharmacology 93 , 209-18, (2015) Parkinson's disease (PD) is a neurological disorder characterized by degeneration of nigrostriatal dopaminergic (DAergic) system. Present treatment targeting to DAergic system solely ameliorated the s... |
|
|
A new class of ammonium ylid for [2,3]-sigmatropic rearrangement reactions: ene-endo-spiro ylids.
Org. Lett. 7 , 2075, (2005) The first examples of sigmatropic rearrangements of ene-endo-spirocyclic, tetrahydropyridine-derived ammonium ylids are reported. Thus, spiro[6.7]-ylids rearrange primarily by a [2,3]-pathway, whereas... |
| Pyridine, 1,2,3,6-tetrahydro- |
| Pyridine, 1,2,3,6-tetrahydro- (8CI)(9CI) |
| MFCD00005949 |
| T6M CUTJ |
| EINECS 211-766-2 |
| 1,2,3,6-Tetrahydropyridine [UN2410] [Flammable liquid] |
| 1,2,3,6-Tetrahydropyridine |